Rezultati

eNauka >  Rezultati >  Prospective Evaluation of Response and Conversion-to-resectability Rate in Patients with Metastatic Colorectal Cancer After 4 Cycles Capox/folfox Plus Bevacizumab - Updated Results From Relevant Trial
Naziv: Prospective Evaluation of Response and Conversion-to-resectability Rate in Patients with Metastatic Colorectal Cancer After 4 Cycles Capox/folfox Plus Bevacizumab - Updated Results From Relevant Trial
Autori: Radosavljević, Davorin  ; Kovcin, Vladimir; Jovanovic Dusan; Manojlović, Nebojša  ; Vrbić, Svetislav; Andrić, Zoran  ; Nikolić, Ivan  ; Pantelić, Aleksandra
Godina: 2011
Publikacija: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Pretraži identifikator
Izdavač: Elsevier
Tip rezultata: Konferencijski rad
Kolacija: vol. 22 br. Suppl. 5 (Meeting Abstract P-0292) str. v101-v101
WoS-ID: 000291260100341
URI: https://enauka.gov.rs/handle/123456789/215518
http://apps.webofknowledge.com/InboundService.do?SID=Q2lH5oN6dlp%40f4EP4jd&product=WOS&UT=000291260100341&SrcApp=SFX&DestFail=http%3A%2F%2Fwww.webofknowledge.com&Init=Yes&action=retrieve&Func=Frame&customersID=SFX&SrcAuth=SFX&IsProductCode=Yes&mode=FullRecord
URL: http://apps.webofknowledge.com/InboundService.do?SID=Q2lH5oN6dlp%40f4EP4jd&product=WOS&UT=000291260100341&SrcApp=SFX&DestFail=http%3A%2F%2Fwww.webofknowledge.com&Init=Yes&action=retrieve&Func=Frame&customersID=SFX&SrcAuth=SFX&IsProductCode=Yes&mode=FullRecord
https://www.sciencedirect.com/journal/annals-of-oncology/vol/22/suppl/S5
Izvor metapodataka: Migracija
Napomena: European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, JUN 22-25, 2011
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

Pronađi DOI


Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.